Dr. Wajiha Javed

Her last served position was Associate Director, Public Health and Research at Getz Pharma. Her key projects in her tenure were being a project director and Co-Investigator for the first-ever 10-year longitudinal cohort and genetic study for cardiovascular disease on a young, disease-naive population. This was with a multidisciplinary global team across continents and was dubbed the mini-Framingham of Asia, looking into local laboratory test values for the Asian population. This included the first-ever Computed Tomography Angiography and bio bank of Pakistan.

She also led implementation projects on animal rabies across Karachi, which included a partnership across veterinary doctors, NIH, local government, and hospitals. It led to a policy shift to stop culling dogs and instead neutering and vaccinating dogs according to the One Health approach of the WHO.

She also pioneered and developed Pakistan’s first primary care private sector health model, integrating around 300 male community health workers, digital referral channels, paperless green clinics, and paperless pharmacies across 16,000 healthcare facilities.

Her role also included being on the Prime Minister's Task Force for local vaccine production and liaising across notable global industries for technology transfer. Over the past years, she has led Pakistan’s first large-scale COVID-19 seroprevalence study and successfully implemented it across 60,000 individuals, and received a personal letter of thanks from the President.

Her experience includes serving as Principal Investigator or Co-Investigator on more than 20 randomized trials and large studies funded by prestigious organizations such as BMGF, DFID/FCDO, USAID, GFATM, TB Wave, and the World Bank. She has published 25 peer-reviewed articles, co-authored three book chapters, and her work has included 40+ research posters that have been presented at leading global forums, including SBCC Singapore, American College of Preventive Cardiology, European Cardiac Society, etc.

 Throughout her career, she has managed multidisciplinary teams of 20+ professionals, led research strategy, monitoring & evaluation systems, and engaged stakeholders across national NGOs and global health partners. She has held key positions in esteemed organizations such as Jhpiego, Greenstar Social Marketing, Pathfinder International, RADS, and AKU. She has extensive field experience, directly overseeing initiatives involving over 59,000 participants, and has contributed to national policy development on NCDs, family planning, MNCH, and communicable diseases through active participation in technical working groups. Additionally, she has played a key role in policy advocacy, training health professionals, device and product pilot studies, and serving on the National Vaccine Taskforce for local vaccine production.

She is passionate about leveraging her research expertise, policy experience, and leadership skills to contribute to impactful health solutions. She offers her services for both public and private sectors.

In the public sector, she has expertise in grant writing, research, program implementation across multisectoral sectors, grantee & sub-grantee management.

In the private commercial health sector, she has expertise in innovative marketing and engagement strategies for pharmaceuticals that are different from traditional marketing for client engagement.

She can offer doctor profiling, so the customer is catered to as per their need. Her work also includes, and she can be consulted for engagement of the lowest segment of first line workers (muhalla doctors) for patient outreach to seek care, leading to pharmaceutical market expansion beyond the traditional by increasing the disease naive pool of patients.

On a personal side, she is an animal activist and runs a shelter from her residence, catering to roughly 160 cats and dogs.